Subscribe to stay informed!
Malvern-based VenatoRx Pharmaceuticals has teamed with a Swiss pharmaceutical company to work on a new class of antibiotics that would address the growing threat…
Outdated reimbursement policies are causing many developers of novel antibiotics that treat drug-resistant superbugs to declare bankruptcy, but Malvern-based VenatoRx Pharmaceuticals believes it…
Before we send you to this site, please subscribe to our daily newsletter.